{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:14:39Z","timestamp":1793999679621,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023MH131"],"award-info":[{"award-number":["ZR2023MH131"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273701"],"award-info":[{"award-number":["82273701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300267"],"award-info":[{"award-number":["82300267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573562"],"award-info":[{"award-number":["82573562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10911-026-09603-0","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:53:43Z","timestamp":1772672023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy"],"prefix":"10.1007","volume":"31","author":[{"given":"Muyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengshen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"9603_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3238\/arztebl.2016.0317","volume":"113","author":"M Heuser","year":"2016","unstructured":"Heuser M, Thol F, Ganser A. Clonal Hematopoiesis of Indeterminate Potential. Dtsch Arztebl Int. 2016;113:317\u201322. https:\/\/doi.org\/10.3238\/arztebl.2016.0317.","journal-title":"Dtsch Arztebl Int"},{"key":"9603_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9\u201316. https:\/\/doi.org\/10.1182\/blood-2015-03-631747.","journal-title":"Blood"},{"key":"9603_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence. N Engl J Med. 2014;371:2477\u201387. https:\/\/doi.org\/10.1056\/NEJMoa1409405.","journal-title":"N Engl J Med"},{"key":"9603_CR4","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1200\/jco.23.01071","volume":"42","author":"S Morganti","year":"2024","unstructured":"Morganti S, Gibson CJ, Jin Q, Santos K, Patel A, Wilson A, et al. Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer. J Clin Oncol. 2024;42:3666\u201379. https:\/\/doi.org\/10.1200\/jco.23.01071.","journal-title":"J Clin Oncol"},{"key":"9603_CR5","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1158\/0008-5472.Can-22-0985","volume":"82","author":"CH Marshall","year":"2022","unstructured":"Marshall CH, Gondek LP, Luo J, Antonarakis ES. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies. Cancer Res. 2022;82:4107\u201313. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-0985.","journal-title":"Cancer Res"},{"key":"9603_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","volume":"392","author":"O Pich","year":"2025","unstructured":"Pich O, Bernard E, Zagorulya M, Rowan A, Pospori C, Slama R, et al. Tumor-Infiltrating Clonal Hematopoiesis. N Engl J Med. 2025;392:1594\u2013608. https:\/\/doi.org\/10.1056\/NEJMoa2413361.","journal-title":"N Engl J Med"},{"key":"9603_CR7","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366:eaan4673. https:\/\/doi.org\/10.1126\/science.aan4673.","journal-title":"Science"},{"key":"9603_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/2767-9764.Crc-24-0522","volume":"5","author":"T Krishnan","year":"2025","unstructured":"Krishnan T, Solar Vasconcelos JP, Titmuss E, Vanner RJ, Schaeffer DF, Karsan A, et al. Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors. Cancer Res Commun. 2025;5:66\u201373. https:\/\/doi.org\/10.1158\/2767-9764.Crc-24-0522.","journal-title":"Cancer Res Commun"},{"key":"9603_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/jco.2016.71.6712","volume":"35","author":"CJ Gibson","year":"2017","unstructured":"Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, et al. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol. 2017;35:1598\u2013605. https:\/\/doi.org\/10.1200\/jco.2016.71.6712.","journal-title":"J Clin Oncol"},{"key":"9603_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jnci\/djad065","volume":"115","author":"C Mayerhofer","year":"2023","unstructured":"Mayerhofer C, Sedrak MS, Hopkins JO, Li T, Tayob N, Faggen MG, et al. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy. J Natl Cancer Inst. 2023;115:981\u20138. https:\/\/doi.org\/10.1093\/jnci\/djad065.","journal-title":"J Natl Cancer Inst"},{"key":"9603_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1158\/1078-0432.Ccr-23-0050","volume":"29","author":"CJ Gibson","year":"2023","unstructured":"Gibson CJ, Fell G, Sella T, Sperling AS, Snow C, Rosenberg SM, et al. Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clin Cancer Res. 2023;29:2551\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0050.","journal-title":"Clin Cancer Res"},{"key":"9603_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/jco-24-01848","volume":"43","author":"C Mayerhofer","year":"2025","unstructured":"Mayerhofer C, Freedman RA, Parsons HA, Partridge AH, Miller PG. Clonal Hematopoiesis in Women With Breast Cancer. J Clin Oncol. 2025;43:861\u20137. https:\/\/doi.org\/10.1200\/jco-24-01848.","journal-title":"J Clin Oncol"},{"key":"9603_CR13","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41577-023-00843-3","volume":"29","author":"R Belizaire","year":"2023","unstructured":"Belizaire R, Wong WHJ, Robinette ML, Ebert BL. Clonal haematopoiesis and dysregulation of the immune system. Nat Rev Immunol. 2023;29:2551\u20138. https:\/\/doi.org\/10.1038\/s41577-023-00843-3.","journal-title":"Nat Rev Immunol"},{"key":"9603_CR14","doi-asserted-by":"publisher","first-page":"20400","DOI":"10.1038\/s41598-022-24130-8","volume":"12","author":"F Vieceli Dalla Sega","year":"2022","unstructured":"Vieceli Dalla Sega F, Palumbo D, Fortini F, D\u2019Agostino Y, Cimaglia P, Marracino L, et al. Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers. Sci Rep. 2022;12:20400. https:\/\/doi.org\/10.1038\/s41598-022-24130-8.","journal-title":"Sci Rep"},{"key":"9603_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2967\/jnumed.122.264871","volume":"64","author":"P Backhaus","year":"2023","unstructured":"Backhaus P, Burg MC, Asmus I, Pixberg M, B\u00fcther F, Breyholz H-J, et al. Initial Results of68Ga-FAPI-46 PET\/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer. J Nucl Med. 2023;64:717\u201323. https:\/\/doi.org\/10.2967\/jnumed.122.264871.","journal-title":"J Nucl Med"},{"key":"9603_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21147\/j.issn.1000-9604.2025.01.03","volume":"37","author":"Q Wang","year":"2025","unstructured":"Wang Q, Zhao F, Zhang H, Chu T, Wang Q, Pan X, et al. Deep learning-based multi-task prediction of response to neoadjuvant chemotherapy using multiscale whole slide images in breast cancer: A multicenter study. Chin J Cancer Res. 2025;37:28\u201347. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.01.03.","journal-title":"Chin J Cancer Res"},{"key":"9603_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/tbcr-23-50","volume":"5","author":"KR Pawloski","year":"2024","unstructured":"Pawloski KR, Barrio AV. Breast surgery after neoadjuvant systemic therapy. Transl Breast Cancer Res. 2024;5:13. https:\/\/doi.org\/10.21037\/tbcr-23-50.","journal-title":"Transl Breast Cancer Res"},{"key":"9603_CR18","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","volume":"48","author":"N Houssami","year":"2012","unstructured":"Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48:3342\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2012.05.023.","journal-title":"Eur J Cancer"},{"key":"9603_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-010-1228-x","volume":"125","author":"G von Minckwitz","year":"2011","unstructured":"von Minckwitz G, Untch M, N\u00fcesch E, Loibl S, Kaufmann M, K\u00fcmmel S, et al. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Res Treat. 2011;125:145\u201356. https:\/\/doi.org\/10.1007\/s10549-010-1228-x.","journal-title":"Breast Cancer Res Treat"},{"key":"9603_CR20","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/bjh.15861","volume":"186","author":"AJ Olszewski","year":"2019","unstructured":"Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, et al. Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy. Br J Haematol. 2019;186:e31\u20135. https:\/\/doi.org\/10.1111\/bjh.15861.","journal-title":"Br J Haematol"},{"key":"9603_CR21","doi-asserted-by":"publisher","first-page":"eabm8729","DOI":"10.1126\/scitranslmed.abm8729","volume":"15","author":"L Fairchild","year":"2023","unstructured":"Fairchild L, Whalen J, D\u2019Aco K, Wu J, Gustafson CB, Solovieff N, et al. Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing. Sci Transl Med. 2023;15:eabm8729. https:\/\/doi.org\/10.1126\/scitranslmed.abm8729.","journal-title":"Sci Transl Med"},{"key":"9603_CR22","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1158\/1078-0432.Ccr-18-1201","volume":"24","author":"CC Coombs","year":"2018","unstructured":"Coombs CC, Gillis NK, Tan X, Berg JS, Ball M, Balasis ME, et al. Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays. Clin Cancer Res. 2018;24:5918\u201324. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1201.","journal-title":"Clin Cancer Res"},{"key":"9603_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13073-024-01286-8","volume":"16","author":"G Yin","year":"2024","unstructured":"Yin G, Liu L, Yu T, Yu L, Feng M, Zhou C, et al. Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy. Genome Med. 2024;16:11. https:\/\/doi.org\/10.1186\/s13073-024-01286-8.","journal-title":"Genome Med"},{"key":"9603_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413\u201321. https:\/\/doi.org\/10.1038\/nbt.2203.","journal-title":"Nat Biotechnol"},{"key":"9603_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester M, Singh AP, Brannon AR, Yu K, Campbell CD, Chiang DY, et al. PureCN: copy number calling and SNV classification using targeted short read sequencing. Source Code Biol Med. 2016;11:13. https:\/\/doi.org\/10.1186\/s13029-016-0060-z.","journal-title":"Source Code Biol Med"},{"key":"9603_CR26","doi-asserted-by":"publisher","first-page":"13342","DOI":"10.1002\/cam4.6032","volume":"12","author":"MS Eshwaraiah","year":"2023","unstructured":"Eshwaraiah MS, Gunda A, Kanakasetty GB, Bakre MM. The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment. Cancer Med. 2023;12:13342\u201351. https:\/\/doi.org\/10.1002\/cam4.6032.","journal-title":"Cancer Med"},{"key":"9603_CR27","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/jco.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. J Clin Oncol. 2010;28:2784\u201395. https:\/\/doi.org\/10.1200\/jco.2009.25.6529.","journal-title":"J Clin Oncol"},{"key":"9603_CR28","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/jco.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25:4414\u201322. https:\/\/doi.org\/10.1200\/jco.2007.10.6823.","journal-title":"J Clin Oncol"},{"key":"9603_CR29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1200\/jco.2015.63.1010","volume":"35","author":"WF Symmans","year":"2017","unstructured":"Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, et al. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017;35:1049\u201360. https:\/\/doi.org\/10.1200\/jco.2015.63.1010.","journal-title":"J Clin Oncol"},{"key":"9603_CR30","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/1078-0432.Ccr-18-0585","volume":"24","author":"P Sharma","year":"2018","unstructured":"Sharma P, L\u00f3pez-Tarruella S, Garc\u00eda-Saenz JA, Khan QJ, G\u00f3mez HL, Prat A, et al. Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel. Clin Cancer Res. 2018;24:5820\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-0585.","journal-title":"Clin Cancer Res"},{"key":"9603_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320\u20137. https:\/\/doi.org\/10.1016\/s0960-9776(03)00106-1.","journal-title":"Breast"},{"key":"9603_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol"},{"key":"9603_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10549-020-05658-7","volume":"181","author":"SA O\u2019Toole","year":"2020","unstructured":"O\u2019Toole SA, Spillane C, Huang Y, Fitzgerald MC, Ffrench B, Mohamed B, et al. Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat. 2020;181:571\u201380. https:\/\/doi.org\/10.1007\/s10549-020-05658-7.","journal-title":"Breast Cancer Res Treat"},{"key":"9603_CR34","doi-asserted-by":"publisher","first-page":"735670","DOI":"10.3389\/fonc.2021.735670","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Luo R, Lu Q, Jiang K, Hong R, Lee K, et al. Miller-Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy. Front Oncol. 2021;11:735670. https:\/\/doi.org\/10.3389\/fonc.2021.735670.","journal-title":"Front Oncol"},{"key":"9603_CR35","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1016\/j.acra.2024.03.035","volume":"31","author":"D Xing","year":"2024","unstructured":"Xing D, Lv Y, Sun B, Chu T, Bao Q, Zhang H. Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive\/HER2-Negative Breast Cancer. Acad Radiol. 2024;31:3524\u201334. https:\/\/doi.org\/10.1016\/j.acra.2024.03.035.","journal-title":"Acad Radiol"},{"key":"9603_CR36","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.31557\/apjcp.2024.25.5.1607","volume":"25","author":"P Rustamadji","year":"2024","unstructured":"Rustamadji P, Wiyarta E, Pramono M, Maulanisa SC. Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer Predicted by CD4+, CD8+, and FOXP3\u2009+\u2009Tumor-Infiltrating Lymphocytes. Asian Pac J Cancer Prev. 2024;25:1607\u201313. https:\/\/doi.org\/10.31557\/apjcp.2024.25.5.1607.","journal-title":"Asian Pac J Cancer Prev"},{"key":"9603_CR37","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1097\/js9.0000000000003060","volume":"111","author":"J Lai","year":"2025","unstructured":"Lai J, Xi Z, Zhu D, Zhang Q, Yang Y, Wang X, et al. Clonal hematopoiesis of indeterminate potential and the risk of breast cancer: a UK Biobank cohort study. Int J Surg. 2025;111:7507\u201316. https:\/\/doi.org\/10.1097\/js9.0000000000003060.","journal-title":"Int J Surg"},{"key":"9603_CR38","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/1078-0432.Ccr-25-2009","volume":"31","author":"SC Reed","year":"2025","unstructured":"Reed SC, Potts CR, Luo LY, Davidson BA, Bergman RE, Kemp JDJ, et al. Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner. Clin Cancer Res. 2025;31:4707\u201319. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-25-2009.","journal-title":"Clin Cancer Res"},{"key":"9603_CR39","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.21037\/gs-21-608","volume":"10","author":"W Wang","year":"2021","unstructured":"Wang W, Liu Y, Zhang H, Zhang S, Duan X, Ye J, et al. Prognostic value of residual cancer burden and Miller-Payne system after neoadjuvant chemotherapy for breast cancer. Gland Surg. 2021;10:3211\u201321. https:\/\/doi.org\/10.21037\/gs-21-608.","journal-title":"Gland Surg"},{"key":"9603_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41581-023-00778-x","volume":"20","author":"C Vlasschaert","year":"2024","unstructured":"Vlasschaert C, Lanktree MB, Rauh MJ, Kelly TN, Natarajan P. Clonal haematopoiesis, ageing and kidney disease. Nat Rev Nephrol. 2024;20:161\u201374. https:\/\/doi.org\/10.1038\/s41581-023-00778-x.","journal-title":"Nat Rev Nephrol"},{"key":"9603_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1373\/clinchem.2011.167494","volume":"58","author":"MA Ferguson","year":"2012","unstructured":"Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680\u20139. https:\/\/doi.org\/10.1373\/clinchem.2011.167494.","journal-title":"Clin Chem"},{"key":"9603_CR42","doi-asserted-by":"publisher","unstructured":"Park J, Kim SU, Choi HJ, Hong SH, Chae MS. Predictive Role of the D-Dimer Level in Acute Kidney Injury in Living Donor Liver Transplantation: A Retrospective Observational Cohort Study. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11020450.","DOI":"10.3390\/jcm11020450"},{"key":"9603_CR43","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.xcrm.2025.101989","volume":"6","author":"MM Buttigieg","year":"2025","unstructured":"Buttigieg MM, Vlasschaert C, Bick AG, Vanner RJ, Rauh MJ. Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes. Cell Rep Med. 2025;6:101989. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101989.","journal-title":"Cell Rep Med"},{"key":"9603_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1158\/1078-0432.Ccr-22-2598","volume":"29","author":"SC Reed","year":"2023","unstructured":"Reed SC, Croessmann S, Park BHCHIP, Happens. Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors. Clin Cancer Res. 2023;29:1403\u201311. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-2598.","journal-title":"Clin Cancer Res"},{"key":"9603_CR45","doi-asserted-by":"publisher","unstructured":"Walsh K. The emergence of clonal hematopoiesis as a disease determinant. J Clin Invest. 2024;134. https:\/\/doi.org\/10.1172\/jci180063.","DOI":"10.1172\/jci180063"},{"key":"9603_CR46","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/blood-2023-187010","volume":"142","author":"IW Tengesdal","year":"2023","unstructured":"Tengesdal IW, Mills TS, Elder A, Patel SB, May M, Schleicher W, et al. Metabolic Alterations Associated with Loss of TET2 Potentiates Inflammation in Myeloid Cells Driving Breast Cancer Progression. Blood. 2023;142:2536\u20132536. https:\/\/doi.org\/10.1182\/blood-2023-187010.","journal-title":"Blood"},{"key":"9603_CR47","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez JC, Coombs CC. What\u2019s hidden in plain sight? Impact of clonal hematopoiesis on the risk and progression of non-hematologic cancers. Haematologica. 2025. https:\/\/doi.org\/10.3324\/haematol.2025.287424.","DOI":"10.3324\/haematol.2025.287424"},{"key":"9603_CR48","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","volume":"18","author":"S Sun","year":"2025","unstructured":"Sun S, Liu L, Zhang J, Sun L, Shu W, Yang Z, et al. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives. J Hematol Oncol. 2025;18:84. https:\/\/doi.org\/10.1186\/s13045-025-01732-z.","journal-title":"J Hematol Oncol"},{"key":"9603_CR49","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1073\/pnas.96.5.2233","volume":"96","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A. 1999;96:2233\u20138. https:\/\/doi.org\/10.1073\/pnas.96.5.2233.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9603_CR50","doi-asserted-by":"publisher","first-page":"11559","DOI":"10.3390\/ijms231911559","volume":"23","author":"M S\u00e1nchez-Canteli","year":"2022","unstructured":"S\u00e1nchez-Canteli M, Juesas L, Garmendia I, Otero-Rosales M, Calvo A, Alvarez-Fern\u00e1ndez M, et al. Tumor-Intrinsic Nuclear \u03b2-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas. Int J Mol Sci. 2022;23:11559. https:\/\/doi.org\/10.3390\/ijms231911559.","journal-title":"Int J Mol Sci"},{"key":"9603_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/etls20170081","volume":"1","author":"M Patel","year":"2017","unstructured":"Patel M. Oncogenic pathways as the basis of primary immune ignorance. Emerg Top Life Sci. 2017;1:421\u20138. https:\/\/doi.org\/10.1042\/etls20170081.","journal-title":"Emerg Top Life Sci"},{"key":"9603_CR52","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41591-024-02854-6","volume":"30","author":"C Vlasschaert","year":"2024","unstructured":"Vlasschaert C, Robinson-Cohen C, Chen J, Akwo E, Parker AC, Silver SA, et al. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury. Nat Med. 2024;30:810\u20137. https:\/\/doi.org\/10.1038\/s41591-024-02854-6.","journal-title":"Nat Med"},{"key":"9603_CR53","doi-asserted-by":"publisher","unstructured":"Anastasiou IA, Kounatidis D, Vallianou NG, Rebelos E, Karampela I, Dalamaga M. Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives. Int J Mol Sci. 2025;27. https:\/\/doi.org\/10.3390\/ijms27010233.","DOI":"10.3390\/ijms27010233"},{"key":"9603_CR54","doi-asserted-by":"publisher","first-page":"102882","DOI":"10.1016\/j.rpth.2025.102882","volume":"9","author":"C Englisch","year":"2025","unstructured":"Englisch C, J\u00e4ger R, Gassner J, Assinger A, Preusser M, Valent P, et al. Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease. Res Pract Thromb Haemost. 2025;9:102882. https:\/\/doi.org\/10.1016\/j.rpth.2025.102882.","journal-title":"Res Pract Thromb Haemost"},{"key":"9603_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdz085","volume":"30","author":"S Hrebien","year":"2019","unstructured":"Hrebien S, Citi V, Garcia-Murillas I, Cutts R, Fenwick K, Kozarewa I, et al. Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial. Ann Oncol. 2019;30:945\u201352. https:\/\/doi.org\/10.1093\/annonc\/mdz085.","journal-title":"Ann Oncol"},{"key":"9603_CR56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024;21:617\u201331. https:\/\/doi.org\/10.1038\/s41569-024-01017-x.","journal-title":"Nat Rev Cardiol"},{"key":"9603_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.seminhematol.2024.01.006","volume":"61","author":"A Singh","year":"2024","unstructured":"Singh A, Balasubramanian S. The crossroads of cancer therapies and clonal hematopoiesis. Semin Hematol. 2024;61:16\u201321. https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.006.","journal-title":"Semin Hematol"},{"key":"9603_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","volume":"80","author":"CRC Zhang","year":"2019","unstructured":"Zhang CRC, Nix D, Gregory M, Ciorba MA, Ostrander EL, Newberry RD, et al. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol. 2019;80:36\u2013e4133. https:\/\/doi.org\/10.1016\/j.exphem.2019.11.008.","journal-title":"Exp Hematol"},{"key":"9603_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13075-023-03014-w","volume":"25","author":"J Park","year":"2023","unstructured":"Park J, An H, Lim J, Park IS, Kim MH, Kim JH, et al. Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2023;25:33. https:\/\/doi.org\/10.1186\/s13075-023-03014-w.","journal-title":"Arthritis Res Ther"},{"key":"9603_CR60","doi-asserted-by":"publisher","first-page":"873896","DOI":"10.3389\/fonc.2022.873896","volume":"12","author":"C Cumbo","year":"2022","unstructured":"Cumbo C, Tarantini F, Zagaria A, Anelli L, Minervini CF, Coccaro N, et al. Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? Front Oncol. 2022;12:873896. https:\/\/doi.org\/10.3389\/fonc.2022.873896.","journal-title":"Front Oncol"},{"key":"9603_CR61","doi-asserted-by":"publisher","first-page":"e0234191","DOI":"10.1371\/journal.pone.0234191","volume":"15","author":"AS Hamy","year":"2020","unstructured":"Hamy AS, Darrigues L, Laas E, De Croze D, Topciu L, Lam GT, et al. Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy. PLoS ONE. 2020;15:e0234191. https:\/\/doi.org\/10.1371\/journal.pone.0234191.","journal-title":"PLoS ONE"},{"key":"9603_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ajkd.2022.08.014","volume":"81","author":"B Kestenbaum","year":"2023","unstructured":"Kestenbaum B, Bick AG, Vlasschaert C, Rauh MJ, Lanktree MB, Franceschini N, et al. Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General Population. Am J Kidney Dis. 2023;81:329\u201335. https:\/\/doi.org\/10.1053\/j.ajkd.2022.08.014.","journal-title":"Am J Kidney Dis"},{"key":"9603_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/tcmj.tcmj_55_19","volume":"31","author":"JY Hsu","year":"2019","unstructured":"Hsu JY, Liu AB. Anticoagulants for cancer-associated ischemic stroke. Tzu Chi Med J. 2019;31:144\u20138. https:\/\/doi.org\/10.4103\/tcmj.tcmj_55_19.","journal-title":"Tzu Chi Med J"},{"key":"9603_CR64","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/cells8080854","volume":"8","author":"F Perner","year":"2019","unstructured":"Perner F, Perner C, Ernst T, Heidel FH. Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation. Cells. 2019;8:854. https:\/\/doi.org\/10.3390\/cells8080854.","journal-title":"Cells"},{"key":"9603_CR65","doi-asserted-by":"publisher","first-page":"NP168","DOI":"10.1177\/1120672120947591","volume":"32","author":"A Insausti-Garcia","year":"2022","unstructured":"Insausti-Garcia A, Reche-Sainz JA, Ruiz-Arranz C, Lopez Vazquez A, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state. Eur J Ophthalmol. 2022;32:NP168\u201372. https:\/\/doi.org\/10.1177\/1120672120947591.","journal-title":"Eur J Ophthalmol"},{"key":"9603_CR66","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1055\/s-0035-1556726","volume":"41","author":"MA Albayati","year":"2015","unstructured":"Albayati MA, Grover SP, Saha P, Lwaleed BA, Modarai B, Smith A. Postsurgical Inflammation as a Causative Mechanism of Venous Thromboembolism. Semin Thromb Hemost. 2015;41:615\u201320. https:\/\/doi.org\/10.1055\/s-0035-1556726.","journal-title":"Semin Thromb Hemost"},{"key":"9603_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00281-022-00913-z","volume":"44","author":"K Amancherla","year":"2022","unstructured":"Amancherla K, Wells JA, Bick AG. Clonal hematopoiesis and vascular disease. Semin Immunopathol. 2022;44:303\u20138. https:\/\/doi.org\/10.1007\/s00281-022-00913-z.","journal-title":"Semin Immunopathol"},{"key":"9603_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fonc.2020.00333","volume":"10","author":"B Li","year":"2020","unstructured":"Li B, Geng R, Wu Q, Yang Q, Sun S, Zhu S, et al. Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer. Front Oncol. 2020;10:333. https:\/\/doi.org\/10.3389\/fonc.2020.00333.","journal-title":"Front Oncol"},{"key":"9603_CR69","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21037\/atm.2020.02.132","volume":"8","author":"LB Song","year":"2020","unstructured":"Song LB, Zhang QJ, Hou XY, Xiu YY, Chen L, Song NH, et al. A twelve-gene signature for survival prediction in malignant melanoma patients. Ann Transl Med. 2020;8:312. https:\/\/doi.org\/10.21037\/atm.2020.02.132.","journal-title":"Ann Transl Med"},{"key":"9603_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41523-021-00237-5","volume":"7","author":"X Yang","year":"2021","unstructured":"Yang X, Cai GX, Han BW, Guo ZW, Wu YS, Lyu X, et al. Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. NPJ Breast Cancer. 2021;7:35. https:\/\/doi.org\/10.1038\/s41523-021-00237-5.","journal-title":"NPJ Breast Cancer"},{"key":"9603_CR71","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41392-025-02254-3","volume":"10","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Wang M, Li Y, Zhang H, Wang Y, Chen X, et al. Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin\/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial. Signal Transduct Target Ther. 2025;10:169. https:\/\/doi.org\/10.1038\/s41392-025-02254-3.","journal-title":"Signal Transduct Target Ther"},{"key":"9603_CR72","doi-asserted-by":"publisher","first-page":"998140","DOI":"10.3389\/fimmu.2022.998140","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Qiao H, Wu F, Sun S, Feng C, Li C, et al. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses. Front Immunol. 2022;13:998140. https:\/\/doi.org\/10.3389\/fimmu.2022.998140.","journal-title":"Front Immunol"},{"key":"9603_CR73","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jtho.2023.05.008","volume":"18","author":"CM Rudin","year":"2023","unstructured":"Rudin CM, Balli D, Lai WV, Richards AL, Nguyen E, Egger JV, et al. Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation. J Thorac Oncol. 2023;18:1222\u201332. https:\/\/doi.org\/10.1016\/j.jtho.2023.05.008.","journal-title":"J Thorac Oncol"},{"key":"9603_CR74","doi-asserted-by":"publisher","first-page":"e008942","DOI":"10.1136\/jitc-2024-008942","volume":"12","author":"T Feng","year":"2024","unstructured":"Feng T, Li Q, Zhu R, Yu C, Xu L, Ying L, et al. Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study. J Immunother Cancer. 2024;12:e008942. https:\/\/doi.org\/10.1136\/jitc-2024-008942.","journal-title":"J Immunother Cancer"},{"key":"9603_CR75","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.18632\/oncotarget.27081","volume":"10","author":"SL Luen","year":"2019","unstructured":"Luen SL, Salgado R, Loi S. Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy. Oncotarget. 2019;10:4612\u20134. https:\/\/doi.org\/10.18632\/oncotarget.27081.","journal-title":"Oncotarget"},{"key":"9603_CR76","doi-asserted-by":"publisher","first-page":"e0280851","DOI":"10.1371\/journal.pone.0280851","volume":"18","author":"IJ Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez IJ, Bernal-Est\u00e9vez DA, Llano-Le\u00f3n M, Bonilla CE, Parra-L\u00f3pez CA. Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients. PLoS ONE. 2023;18:e0280851. https:\/\/doi.org\/10.1371\/journal.pone.0280851.","journal-title":"PLoS ONE"},{"key":"9603_CR77","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1038\/s41598-022-12108-5","volume":"12","author":"C Urue\u00f1a","year":"2022","unstructured":"Urue\u00f1a C, Lasso P, Bernal-Estevez D, Rubio D, Salazar AJ, Olaya M, et al. The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy. Sci Rep. 2022;12:7981. https:\/\/doi.org\/10.1038\/s41598-022-12108-5.","journal-title":"Sci Rep"},{"key":"9603_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","volume":"161","author":"CS Marnell","year":"2021","unstructured":"Marnell CS, Bick A, Natarajan P. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol. 2021;161:98\u2013105. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.004.","journal-title":"J Mol Cell Cardiol"},{"key":"9603_CR79","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12185-025-04038-5","volume":"122","author":"N Sato","year":"2025","unstructured":"Sato N, Goyama S, Kitamura T. ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights. Int J Hematol. 2025;122:327\u201340. https:\/\/doi.org\/10.1007\/s12185-025-04038-5.","journal-title":"Int J Hematol"},{"key":"9603_CR80","first-page":"10e11","volume":"32","author":"C Zhang","year":"2026","unstructured":"Zhang C, Goldsmith SR, Htut M, Rhee JW, Vyas V, Clark MC, et al. CRISPR Knockdown of CHIP Genes in Macrophages Drives Increased Production of Inflammatory Cytokines in CAR-T Cell Therapy. Transpl Cell Ther. 2026;32:10e11. 10.e15.","journal-title":"Transpl Cell Ther"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-026-09603-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:23:12Z","timestamp":1775820192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-026-09603-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9603"],"URL":"https:\/\/doi.org\/10.1007\/s10911-026-09603-0","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the guidelines of the Declaration of Helsinki. This study was approved by the Institutional Review Board of The Second Qilu Hospital of Shandong University [Approval No.: KYLL-2020(KJ)P-0195], and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12"}}